Retension Pharmaceuticals, Inc.: director Cheruvu Pavan received 5,636 shares

What happened

• The Form 4 reports that Cheruvu Pavan, a director, received a grant of options covering 5,636 shares (derivative) on Oct 13, 2026, at $0.00 per share for a reported value of $0.00.

Key details

• Transaction date and price: Oct 13, 2026 at $0.00 per share.
• Shares owned after the transaction: not reported in the provided filing details.
• Footnote F1: option award granted pursuant to the issuer's 2026 Equity Incentive Plan. Vesting: 25% vests on the first anniversary of the grant date, with the remaining options vesting in 12 quarterly increments thereafter, subject to continued service on each vesting date.
• Filing date: Oct 13, 2026; no late filing indicated in the Form 4.

Why it may matter

• This was a stock option grant (derivative), not a market sale or purchase, so no shares were sold in the open market as part of this transaction.
• A filing does not show why the insider traded or why the company acted.